Baricitinib
RxNorm 2588561· BARICITINIB· ORAL
Janus Kinase Inhibitor [EPC] · Eli Lilly and Company
Adverse events
Most frequently reported events (FDA FAERS). Report frequency does not imply causation.
- drug ineffective732
- off label use667
- covid-19447
- rheumatoid arthritis352
- pulmonary embolism302
- pneumonia274
- headache261
- herpes zoster239
- death235
- nausea228
- deep vein thrombosis213
- fatigue185
- weight increased184
- arthralgia181
- therapy interrupted178
- urinary tract infection176
View more: Full FDA label on DailyMed →Label effective 20220510